Bill

Bill > SB62


MD SB62

MD SB62
Pharmacists - Nicotine Replacement Therapy Medication


summary

Introduced
01/12/2022
In Committee
03/30/2022
Crossed Over
02/24/2022
Passed
04/01/2022
Dead
Signed/Enacted/Adopted
05/12/2022

Introduced Session

2022 Regular Session

Bill Summary

Pharmacists - Aids for the Cessation of Tobacco Product Use

AI Summary

This bill allows pharmacists to prescribe and dispense nicotine replacement therapy (NRT) medications approved by the U.S. Food and Drug Administration as aids for the cessation of tobacco product use. The bill requires the Maryland Board of Pharmacy to adopt regulations by September 1, 2023, establishing standard procedures for pharmacists to prescribe and dispense NRT medications, refer patients to their primary care practitioners, and maintain records of the dispensing. The bill also requires pharmacists to complete a training program approved by the Board, with an exception for those who have already undergone such training as part of their formal educational program. The bill takes effect on October 1, 2022.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Approved by the Governor - Chapter 320 (on 05/12/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...